Top compounds associated with response to RPEL1


Feature Type Standardized
Nominal ANOVA
mRNA manumycin A CTRPv2 pan-cancer AAC -0.037 0.3
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.038 0.3
mRNA FK866 CTRPv2 pan-cancer AAC -0.043 0.3
mRNA momelotinib CTRPv2 pan-cancer AAC -0.039 0.3
mRNA QL-X-138 GDSC1000 pan-cancer AAC 0.033 0.3
mRNA lapatinib UHNBreast pan-cancer AAC -0.33 0.3
mRNA itraconazole CTRPv2 pan-cancer AAC 0.043 0.3
mRNA BIX-01294 CTRPv2 pan-cancer AAC -0.039 0.3
mRNA GSK-650394 GDSC1000 pan-cancer AAC 0.037 0.3
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.042 0.3
Download CSV